The inaugural ESMO Targeted Anticancer Therapies Asia Congress 2025 will be held from 18-20 July 2025 in Hong Kong SAR, China!
This exciting event is a pioneering platform poised to facilitate accelerated oncology drug development across the Asia-Pacific Region, and aims to bring together clinician, academia, pharmaceutical industry partners and patient engagement voices to create a multidisciplinary forum for new ideas in early-phase clinical and novel anti-cancer therapies.
Together with our industry partners, we believe ESMO TAT Asia will help catalyse the development of advanced oncological treatments and foster patient-centred approaches, offering valuable opportunities for growth, collaboration and knowledge sharing.
How can I participate in ESMO TAT Asia 2025?
Contact the ESMO TAT Asia Congress 2025 Secretariat for more details and we look forward to hearing from you!